Notable Recent Publications

These are some recent publications which give a flavour of the research from the Barclay lab. For a complete list of publications, please see below.

Species difference in ANP32A underlies influenza A virus polymerase host restriction. Nature (2016).
Jason S. Long, Efstathios S. Giotis, Olivier Moncorgé, Rebecca Frise, Bhakti Mistry, Joe James, Mireille Morisson, Munir Iqbal, Alain Vignal, Michael A. Skinner & Wendy S. Barclay

This paper identified a key factor that explained why the polymerases from avian influenza viruses are restricted in humans.  For more, please see the associated New and Views.

See our latest ANP32 papers here: eLIFE, Journal of Virology, Journal of Virology.

The mechanism of resistance to favipiravir in influenza. PNAS (2018).
Daniel H. GoldhillAartjan J. W. te VelthuisRobert A. FletcherPinky LangatMaria ZambonAngie Lackenby & Wendy S. Barclay

This paper showed how influenza could evolve resistance to favipiravir, an antiviral that may be used to treat influenza. The residue that mutated to give resistance was highly conserved suggesting that the mechanism of resistance may be applicable to other RNA viruses.

Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. Plos Path. (2018).
Hui Li*, Konrad C. Bradley*, Jason S. Long, Rebecca Frise, Jonathan W. Ashcroft, Lorian C. Hartgroves, Holly Shelton, Spyridon Makris, Cecilia Johansson, Bin Cao & Wendy S. Barclay

Why do avian influenza viruses like H5N1 cause such severe disease in humans? This paper demonstrated that H5N1 viruses replicate better than human viruses in myeloid cells from mice leading to a cytokine storm and more severe disease.


BibTex format

author = {Rodriguez-Manzano, J and Malpartida-Cardenas, K and Moser, N and Pennisi, I and Cavuto, M and Miglietta, L and Moniri, A and Penn, R and Satta, G and Randell, P and Davies, F and Bolt, F and Barclay, W and Holmes, A and Georgiou, P},
doi = {10.1021/acscentsci.0c01288},
journal = {ACS Central Science},
pages = {307--317},
title = {Handheld point-of-care system for rapid detection of SARS-CoV-2 extracted RNA in under 20 min},
url = {},
volume = {7},
year = {2021}

RIS format (EndNote, RefMan)

AB - The COVID-19 pandemic is a global health emergency characterized by the high rate of transmission and ongoing increase of cases globally. Rapid point-of-care (PoC) diagnostics to detect the causative virus, SARS-CoV-2, are urgently needed to identify and isolate patients, contain its spread and guide clinical management. In this work, we report the development of a rapid PoC diagnostic test (<20 min) based on reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) and semiconductor technology for the detection of SARS-CoV-2 from extracted RNA samples. The developed LAMP assay was tested on a real-time benchtop instrument (RT-qLAMP) showing a lower limit of detection of 10 RNA copies per reaction. It was validated against extracted RNA from 183 clinical samples including 127 positive samples (screened by the CDC RT-qPCR assay). Results showed 91% sensitivity and 100% specificity when compared to RT-qPCR and average positive detection times of 15.45 ± 4.43 min. For validating the incorporation of the RT-LAMP assay onto our PoC platform (RT-eLAMP), a subset of samples was tested (n = 52), showing average detection times of 12.68 ± 2.56 min for positive samples (n = 34), demonstrating a comparable performance to a benchtop commercial instrument. Paired with a smartphone for results visualization and geolocalization, this portable diagnostic platform with secure cloud connectivity will enable real-time case identification and epidemiological surveillance.
AU - Rodriguez-Manzano,J
AU - Malpartida-Cardenas,K
AU - Moser,N
AU - Pennisi,I
AU - Cavuto,M
AU - Miglietta,L
AU - Moniri,A
AU - Penn,R
AU - Satta,G
AU - Randell,P
AU - Davies,F
AU - Bolt,F
AU - Barclay,W
AU - Holmes,A
AU - Georgiou,P
DO - 10.1021/acscentsci.0c01288
EP - 317
PY - 2021///
SN - 2374-7943
SP - 307
TI - Handheld point-of-care system for rapid detection of SARS-CoV-2 extracted RNA in under 20 min
T2 - ACS Central Science
UR -
UR -
VL - 7
ER -